Skip to Content

N899 300 (Nizatidine 300 mg)

Pill with imprint N899 300 is Beige, Capsule-shape and has been identified as Nizatidine 300 mg. It is supplied by Teva Pharmaceuticals USA.

Nizatidine is used in the treatment of gerd; erosive esophagitis; stomach ulcer; indigestion; duodenal ulcer and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Nizatidine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for N899 300

Nizatidine 300 mg N899 300

Nizatidine

Imprint
N899 300
Strength
300 mg
Color
Beige
Size
19.00 mm
Shape
Capsule-shape
Availability
Rx and/or OTC
Drug Class
H2 antagonists
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
National Drug Code (NDC)
00093-1066

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.